Improving Transparency of Clinical Trial Data

Practical Issues forPatients, Family and the Public

Availability ~ Accessibility ~ Intelligibility

Stop Gaps ~ Implications

Doris A. Fuller

Chief of Research & Public Affairs

Treatment Advocacy Center

AVAILABILITY

AVAILABILITY

DISCOVERABILITY

ACCESSIBILITY

INTELLIGIBILITY

STOP GAPS - Availability

STOP GAPS - Accessibility

STOP GAPS - Intelligibility

IMPLICATIONS

IMPLICATIONS

IMPLICATIONS

IMPLICATIONS